Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis

Abstract Background Acute oral mucositis has been infrequently studied in the patients with head and neck squamous cell carcinoma (HNSCC) receiving once-weekly cisplatin-based chemoradiotherapy (CRT). Hence, this analysis was conducted to explore the various aspects of the same. Results The overall...

Full description

Bibliographic Details
Published in:	Journal of the Egyptian National Cancer Institute
Main Authors:	Vanita Noronha, Vijay M. Patil, Gunjesh Kumar Singh, Amit Joshi, Nandini Menon, Sarbani Ghosh Lashkar, Vijayalakshmi Mathrudev, Kavita Nawale Satam, Kumar Prabhash
Format:	Article
Language:	English
Published:	SpringerOpen 2021-05-01
Subjects:	Acute oral mucositis Head and neck cancer Chemoradiation
Online Access:	https://doi.org/10.1186/s43046-021-00069-1

Similar Items

Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once‐a‐week versus once‐every‐3‐weeks cisplatin
by: Nandini S. Menon, et al.
Published: (2022-11-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

Factors affecting timing of surgery following neoadjuvant chemoradiation for esophageal cancer
by: Shannon J. Jiang, et al.
Published: (2023-12-01)

Tailoring treatment for esophageal cancer: a retrospective comparison of chemoradiation with and without esophagectomy
by: Piyapasara Toapichattrakul, et al.
Published: (2025-09-01)

Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01)

THE RESULTS OF CHEMORADIATION FOR CERVICAL CANCER USING FTORAFUR
by: D. D. Sakaeva, et al.
Published: (2017-02-01)

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors
by: Han-Gil Kim, et al.
Published: (2021-01-01)

Immunotherapy Plus Chemoradiation Improves Overall Survival in Stage IV Esophageal Cancer: A Cohort Study
by: Saber Amin, et al.
Published: (2024-01-01)

Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study
by: Dongeun Lee, et al.
Published: (2024-11-01)

Accelerated hypo fractionated radiation therapy with low dose cisplatin in oral tongue cancer using intensity modulated radiation therapy with simultaneous integrated boost: A prospective study
by: Venkataraman Priyadarshini, et al.
Published: (2025-04-01)

Effect of GSDMB polymorphism on sensitivity to chemoradiation therapy for cervical cancer
by: Ni Zhong, et al.
Published: (2021-12-01)

Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy
by: Malekzada Freschta, et al.
Published: (2024-11-01)

The Quality of Life of Patients with Hereditary Nonpolyposis Colorectal Cancer Undergoing Preoperative Chemoradiation
by: Valeriu Aurelian Chirica, et al.
Published: (2020-09-01)

Efficacy and safety of low-dose celecoxib with chemoradiation in locally advanced head-and-neck squamous cell carcinoma
by: Rethinesh Kumar T, et al.
Published: (2024-07-01)

Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
by: Sushma Agrawal
Published: (2013-01-01)

Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer
by: Shashank Sama, et al.
Published: (2023-01-01)

Retrospective evaluation of oral complications following radiotherapy and chemoradiation in patients with head and neck Cancer
by: Radhika R. Pai, et al.
Published: (2025-07-01)

Preoperative chemoradiation in carcinoma esophagus: Experience from a tertiary cancer center in India
by: Harjot Kaur Bajwa, et al.
Published: (2018-01-01)

Circulating concentrations of citrulline, neopterin, kynurenine, and tryptophan during chemoradiation in patients with cervical carcinoma
by: Pospíšková Markéta, et al.
Published: (2021-11-01)

Concomitant chemoradiotherapy, brachytherapy, and parametrial boost versus concomitant chemoradiation and brachytherapy alone in locally advanced cervical carcinoma: A prospective and comparative study
by: Saptarshi Banerjee, et al.
Published: (2023-04-01)

Preoperative Chemoradiation versus Chemotherapy in Locally Advanced Resectable Esophageal Cancer: A Retrospective Study
by: Waseem Abbas, et al.
Published: (2022-07-01)

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
by: Dewas Claire, et al.
Published: (2012-11-01)

The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization
by: Tomomi Yasue, et al.
Published: (2025-07-01)

A urethral clear cell carcinoma case successfully treated with organ preservation surgery and adjuvant chemoradiation
by: Seok Ho Lee, et al.
Published: (2022-09-01)

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
by: Kwanza T. Warren, et al.
Published: (2019-03-01)

Analysis of Patients with Glioblastoma Treated with Standard 6-Week Chemoradiation Followed by Temozolomide: Treatment Outcomes and Prognostic Factors
by: Sojung Lee, et al.
Published: (2025-02-01)

A prospective randomized comparison of concurrent chemoradiation with neoadjuvant and adjuvant chemotherapy with concurrent chemoradiation alone for locally advanced carcinoma cervix
by: Rahul Singh, et al.
Published: (2019-01-01)

Bendamustine in the third line or beyond in metastatic, recurrent, or relapsed head-and-neck cancers: A retrospective observational study
by: Vijay Patil, et al.
Published: (2022-01-01)

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center
by: Stephane Thibodeau, et al.
Published: (2023-01-01)

Locally advanced female urethral adenocarcinoma of enteric origin: The role of adjuvant chemoradiation and brief review
by: Ling-Ping Chen, et al.
Published: (2011-04-01)

Chemoradiation of locally advanced biliary cancer: A PRISMA‐compliant systematic review
by: Silvia Bisello, et al.
Published: (2024-12-01)

DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
by: Shinichiro Hasegawa, et al.
Published: (2023-01-01)

Results of combined and chemoradiation treatment of patients with thoracic esophageal cancer according to the data of the regional cancer center
by: E. A. Toneev, et al.
Published: (2023-11-01)

Preoperative Chemoradiation (Modified Eilber Protocol) Versus Preoperative/Postoperative Radiotherapy for Soft Tissue Sarcomas: A Population-Based Analysis
by: Greg M. Padmore, et al.
Published: (2025-06-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Application of Machine Learning to Metabolomic Profile Characterization in Glioblastoma Patients Undergoing Concurrent Chemoradiation
by: Orwa Aboud, et al.
Published: (2023-02-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Comparing efficacy and safety of weekly vs. triweekly cisplatin concurrently with radiotherapy for locally advanced head and neck cancer: Systematic review and meta-analysis
by: Mohammed Amine Saâd, et al.
Published: (2025-06-01)

Neoadjuvant chemoradiation and surgical excision versus definitive radiotherapy for locally advanced cervix uteri carcinoma: in terms of early and late complications and locoregional recurrence
by: Hisham Khalifa, et al.
Published: (2025-06-01)